In addition, it has been shown that IL-35 secreted by breast cancer cells also promotes the IL-10 production and sharply decreases the secretion of Th1-type cytokine IFN-γ and IL-17 in conventional T cells (28). This evidence concerns the gene IFNG and breast carcinoma.